Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 57.05

-0.6%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (2202)	12/2/2000 7:56:36 PM
From: tommysdad	Read Replies (3) of 52153

<<But then again there's the data point I have from a friend at a fairly recent IPO that's been selling services to both pharmas and biotechs. His view: "Good luck trying to get a phone call returned from a pharma after lunch on a Friday...">> Well, sometimes breakthrough drugs do actually come from pharma: biz.yahoo.com STI-571 is truly remarkable. And unlikely to have come from a biotech, IMO. Novartis was in the kinase game big and early.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next